Redwood Pharma AB is a pharmaceutical company based in Stockholm, Sweden. The organization focuses on the development of innovative therapies for ophthalmic conditions, particularly those related to dry eye disease. Redwood Pharma aims to address unmet medical needs in this area through its research and development efforts.
The company is known for its proprietary drug delivery technologies, which are designed to enhance the effectiveness of treatments for eye-related ailments. Redwood Pharma's approach combines scientific expertise with a commitment to improving patient outcomes in the field of ophthalmology. The company is actively engaged in clinical trials and collaborations to advance its product pipeline and bring new therapies to market.